PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 29 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Aqueous extracts showed nephroprotective effects and the ability to maintain uric acid homeostasis via gut microbiota regulation in rat and mice models [PMID:41456824, PMID:39654614]
Methyl rosmarinate from O. aristatus improved insulin sensitivity in diabetic mice by inhibiting PTP1B [PMID:41151449]
Standardized extract (400 mg/kg) inhibited NAFLD progression and reduced liver enzymes (ALT/AST) and serum glucose in obese mice [PMID:36678606]
Ethanolic and aqueous extracts dose-dependently improved bone strength and flexibility in ovariectomized rats [PMID:28926512]
Extracts attenuated pathology through anti-inflammatory, anti-oxidative, and beta-amyloid inhibitory activities in cell and mice models [PMID:37704121]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 30725664 (2026) — Kidney tea [Orthosiphon aristatus (Blume) Miq.] improves diabetic nephropathy via regulating gut microbiota and ferroptosis. · Frontiers in pharmacology
- 2.PMID: 41456824 (2026) — Elucidating the therapeutic mechanism of Orthosiphon aristatus in hyperuricemic nephropathy: An integrated microbiome-metabolomics approach. · Journal of ethnopharmacology
- 3.PMID: 32477146 (2020) — A Systematic Review of the Protective Actions of Cat's Whiskers (Misai Kucing) on the Central Nervous System. · Frontiers in pharmacology
- 4.PMID: 38222982 (2024) — The complete chloroplast genome of Orthosiphon aristatus (Blume) Miq. (Lamiaceae). · Mitochondrial DNA. Part B, Resources
- 5.PMID: 37355082 (2023)